Prelude Therapeutics
Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT1419, a myeloid cell leukemia-1 inhibitor, which is in Phase 1 clinical tria...
Prelude Therapeutics Logo
About Prelude Therapeutics
Prelude Therapeutics Incorporated operates as a biopharmaceutical company. The Company develops and designs a pipeline of novel, orally bioavailable, and small molecule therapies that target key drivers of cancer cell growth. Prelude Therapeutics serves patients worldwide.
Address
175 Innovation Boulevard,
Wilmington, 19805
United States
Year founded
2016
Number of employees
100-200
Report inaccurate data
Request an update to help us keep the brand up-to-date.
